Company:  AFFIMED N.V. (AFMD)
Form Type:  6-K
Filing Date:  6/23/2022 
CIK:  0001608390 
Address:  IM NEUENHEIMER FELD 582, 69120 
City, State, Zip:  HEIDELBERG,  000000 
Telephone:  49-6221-65307 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.14  
Change: 
0.08 (3.88%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$312.32M
Trade AFMD now with 

© 2022  
Description of Business
We are a clinical-stage immuno-oncology company focused on discovering and developing highly targeted cancer immunotherapies. Our product candidates represent an innovative approach to cancer treatment that seeks to harness the body's own immune defenses to fight tumor cells. The most potent cells of the human defense arsenal are types of white blood cells called innate immune cells (Natural Killer cells, or NK cells, and macrophages) and T cells. Leveraging our fit-for-purpose ROCK® platform, we develop proprietary, next-generation bispecific and trispecific antibodies, so-called innate cell engagers, which are designed to direct innate immune cells and establish a bridge to cancer cells. Our innate cell engagers have the ability to bring innate immune cells into the proximity of tumor cells and trigger an activation cascade that leads to the destruction of cancer cells.
Register and access this filing in:     
  FORM 6-K
    SIGNATURES